Delivery Order SPE2DB24D8002-SPE2DB25FJNJB
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, with a ceiling value of $10,030.86 and a period of performance through February 21, 2024. Dakota Drug, Inc. is an established federal contractor, holding a single-award Indefinite Delivery Contract (IDC) with the DLA valued at...
- This is a Firm Fixed Price Delivery Order (SPE2DX15D8002|SPE2DX24F2UQ5) awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a ceiling value of $5,788.98 and a performance period ending on January 24, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,907.00, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medical products. The contract has a firm fixed price pricing type and a period of performance through November 6, 2024. This delivery order is issued under Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medical products. The contract has a firm fixed-price of $5,673.31 and a period of performance through January 31, 2025. Dakota Drug, Inc. is the prime contractor, and there are no subcontractors mentioned. The contract is not set aside and is part of the DLA Troop Support Medical's ECAT...
- This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract has a firm fixed price of $10,101.69 and a completion date of June 16, 2025. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,649.64 contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, with a period of performance ending on March 21, 2024. This award was not set aside. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the...
- This federal contract award, with a value of $3,306.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This single-award...
- The Defense Logistics Agency awarded a $10,101.69 firm fixed price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Benlysta 200 mg/ml auto-injector medication. The contract, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, carries no set-aside designation. This delivery order is issued under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop...
- This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJNGD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $9,575.20, is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product. This award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of BENLYSTA 200 mg/mL autoinjectors. The contract has a ceiling value of $5,586.06 and an ultimate completion date of July 16, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to place delivery orders for a comprehensive range of pharmaceutical items to...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJNJBDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR, a pharmaceutical product, with a ceiling value of $10,536.26 and a performance period ending on March 19, 2025. The contract is not set aside for any specific business type. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows it to provide a comprehensive range of medical items to support U.S. Armed Forces medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 3/18/25 |